Please login to the form below

Not currently logged in


This page shows the latest Clinigen news and features for those working in and with pharma, biotech and healthcare.

Quantum Pharma confirms Clinigen takeover bid

Quantum Pharma confirms Clinigen takeover bid

Clinigen is comprised of four separate businesses - spanning contract research, managed access and specialty medicines sales - which are a fairly close match for Quantum's activities. ... Clinigen confirmed the move this morning but stressed its proposal

Latest news

  • Clinigen acquires Idis for £225m Clinigen acquires Idis for £225m

    Acquisition makes them the global leader in unlicensed medicines.  . Clinigen Group is to acquire unlicensed medicines supplier Idis for £225m. ... The ethical unlicensed supply market is estimated to be worth in excess of $5bn and upon completion,

  • Eisai resubmits Fycompa to G-BA for pricing assessment Eisai resubmits Fycompa to G-BA for pricing assessment

    This prompted Eisai to suspend distribution of Fycompa in Germany, with the exception of an access programme managed by Clinigen for individual patients, until a favourable resolution can be reached.

  • Eisai lines-up Fycompa access programme for Germany Eisai lines-up Fycompa access programme for Germany

    data. Now Eisai has partnered with Clinigen Global Access Programs (GAP) on a named patient access programme that it said “ensures continued supply of anti-epilepsy treatment at no cost to ... For this reason, Eisai has partnered with a specialist

  • BTG extends orphan drug distribution partnership with Clinigen

    Deal covers treatment for overexposure to chemotherapy. UK-based Clinigen Group is to manage a named patient programme for an investigational orphan drug to treat overexposure to chemotherapyon behalf of BTG ... Uridine triacetate is the third product

  • Clinigen reshuffles management to prepare for growth

    As part of its management reshuffle Clinigen has also appointed a trio of new senior vice presidents to run its three operating businesses. ... Mark Corbett will lead Clinigen GAP, Lorann Morse will become senior vice president for Clinigen CTS and David

More from news
Approximately 5 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    Allen has over 20 years’ experience as an executive director, non-executive director and chairman in a range of life sciences companies and he is currently non-executive chairman of Clinigen,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Attigo (part of the Mednet Group)

    Clinigen. Crohns and Colitis Department for International Development. Eisai. Gilead. Janssen.

  • Real world project management

    The Author. Debra Ainge is Head of Project Management at Clinigen GAP. ... 44 (0) 1283 495 010. Address:. Clinigen. Pitcairn House. Crown Square, First Avenue.

  • Clinigen

    Clinigen Global Access Programs specializes in the consultancy, development, management and implementation of access programs across the product lifecycle for biotechnology and pharmaceutical companies. ... Address:. Clinigen. Pitcairn House , Crown

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....